r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

KB

Kumar Budur

Insider · Chief Medical Officer · HRMY

Kumar Budur files insider transactions with the SEC as a chief medical officer of Harmony Biosciences Holdings. We hold 2 disclosed purchases and sales filed since 26 January 2024, 2 of them in the last 90 days.

  • Files forHRMY
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure9 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 24 January 2024 — 8 September 2026Chief Medical Officer · Harmony Biosciences Holdings 39 Form 4 lines · source: SEC Form 4

Every transaction

39 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
39 of 39 shown
8 Sep 20269 Sep 2026SEC Form 41 dsold on the open marketHarmony Biosciences Holdings4,500 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dsold on the open marketHarmony Biosciences Holdings1,000 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdings12,200 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdings10,754 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dsold on the open marketHarmony Biosciences Holdings22,954 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative12,200 sharesdown −1.1%up +0.0%
8 Sep 20269 Sep 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative10,754 sharesdown −1.1%up +0.0%
4 Sep 20269 Sep 2026SEC Form 45 dsold on the open marketHarmony Biosciences Holdings5,500 sharesdown −1.5%up +0.0%
1 May 202618 May 2026SEC Form 417 dexercised options overnot a tradeHarmony Biosciences Holdings18,750 sharesup +30.8%up +39.5%
1 May 202618 May 2026SEC Form 417 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings8,882 sharesup +30.8%up +39.5%
1 May 202618 May 2026SEC Form 417 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative18,750 sharesup +30.8%up +39.5%
25 Jan 202626 Jan 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdings2,662 sharesup +13.0%up +11.4%
25 Jan 202626 Jan 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative2,662 sharesup +13.0%up +11.4%
25 Jan 202626 Jan 2026SEC Form 41 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings1,372 sharesup +13.0%up +11.4%
25 Jan 202626 Jan 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative2,662 sharesup +13.0%up +11.4%
25 Jan 202626 Jan 2026SEC Form 41 dexercised options overnot a tradeHarmony Biosciences Holdings2,662 sharesup +13.0%up +11.4%
25 Jan 202626 Jan 2026SEC Form 41 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings1,372 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dexercised options overnot a tradeHarmony Biosciences Holdings2,188 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings1,153 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative2,188 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative2,188 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dexercised options overnot a tradeHarmony Biosciences Holdings2,188 sharesup +13.0%up +11.4%
24 Jan 202626 Jan 2026SEC Form 42 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings1,153 sharesup +13.0%up +11.4%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeHarmony Biosciences Holdingsderivative42,600 sharesup +13.2%up +11.4%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeHarmony Biosciences Holdingsderivative12,200 sharesup +13.2%up +11.4%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeHarmony Biosciences Holdingsderivative42,600 sharesup +13.2%up +11.4%
22 Jan 202626 Jan 2026SEC Form 44 dwas grantednot a tradeHarmony Biosciences Holdingsderivative12,200 sharesup +13.2%up +11.4%
1 May 20259 May 2025SEC Form 48 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative18,750 sharesup +39.4%up +22.2%
1 May 20259 May 2025SEC Form 48 dexercised options overnot a tradeHarmony Biosciences Holdings18,750 sharesup +39.4%up +22.2%
1 May 20259 May 2025SEC Form 48 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings8,869 sharesup +39.4%up +22.2%
25 Jan 202528 Jan 2025SEC Form 43 dwas grantednot a tradeHarmony Biosciences Holdingsderivative37,400 sharesup +9.5%up +8.3%
25 Jan 202528 Jan 2025SEC Form 43 dwas grantednot a tradeHarmony Biosciences Holdingsderivative10,650 sharesup +9.5%up +8.3%
24 Jan 202528 Jan 2025SEC Form 44 dexercised options overnot a tradeHarmony Biosciences Holdingsderivative2,187 sharesup +9.5%up +8.3%
24 Jan 202528 Jan 2025SEC Form 44 dexercised options overnot a tradeHarmony Biosciences Holdings2,187 sharesup +9.5%up +8.3%
24 Jan 202528 Jan 2025SEC Form 44 dhad shares withheld for taxnot a tradeHarmony Biosciences Holdings1,151 sharesup +9.5%up +8.3%
1 May 20243 May 2024SEC Form 42 dwas grantednot a tradeHarmony Biosciences Holdingsderivative75,000 sharesup +37.5%up +31.8%
1 May 20243 May 2024SEC Form 42 dwas grantednot a tradeHarmony Biosciences Holdingsderivative75,000 sharesup +37.5%up +31.8%
24 Jan 202426 Jan 2024SEC Form 42 dwas grantednot a tradeHarmony Biosciences Holdingsderivative42,500 sharesup +35.6%up +33.9%
24 Jan 202426 Jan 2024SEC Form 42 dwas grantednot a tradeHarmony Biosciences Holdingsderivative8,750 sharesup +35.6%up +33.9%

Both percentages are the stock’s move, not Kumar Budur’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 39 of the 39 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.